STAGE IVB UTERINE CORPUS CANCER AJCC V8
Clinical trials for STAGE IVB UTERINE CORPUS CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB UTERINE CORPUS CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB UTERINE CORPUS CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug combo targets recurrent gynecologic cancers
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib combined with radiation therapy for people whose gynecologic cancer (like ovarian, uterine, or cervical) has returned. The goal is to find the safest dose and see if the combination can shrink tumors. About 24 participants wi…
Matched conditions: STAGE IVB UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:53 UTC
-
New drug combo trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will take …
Matched conditions: STAGE IVB UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:52 UTC
-
Chemo mist trial aims to shrink abdominal tumors with fewer side effects
Disease control Recruiting nowThis early-phase trial is testing a procedure called PIPAC, which turns liquid chemotherapy into a fine mist and sprays it directly into the abdomen during a keyhole surgery. It is for people with ovarian, uterine, appendix, colorectal, or stomach cancer that has spread to the li…
Matched conditions: STAGE IVB UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 11:48 UTC
-
Electric field therapy worn like a vest shows promise against tough cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields to disrupt cancer cell growth, combined with standard drugs (cabozantinib or nab-paclitaxel plus atezolizumab). About 43 adults with advanced solid tumors in the abdomen or chest that have s…
Matched conditions: STAGE IVB UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:47 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immune syst…
Matched conditions: STAGE IVB UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:04 UTC